184 related articles for article (PubMed ID: 38135175)
1. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
Thoreau B; Mouthon L
Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Distler O; Ofner C; Huscher D; Jordan S; Ulrich S; Stähler G; Grünig E; Held M; Ghofrani HA; Claussen M; Lange TJ; Klose H; Rosenkranz S; Vonk-Noordegraaf A; Vizza CD; Delcroix M; Opitz C; Pausch C; Scelsi L; Neurohr C; Olsson KM; Coghlan JG; Halank M; Skowasch D; Behr J; Milger K; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Wilkens H; Pittrow D; Hoeper MM; Ewert R
Rheumatology (Oxford); 2024 Apr; 63(4):1139-1146. PubMed ID: 37462520
[TBL] [Abstract][Full Text] [Related]
5. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension complicating connective tissue diseases.
Hassoun PM
Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O
Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue disease-related pulmonary arterial hypertension.
Thakkar V; Lau EM
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):22-38. PubMed ID: 27421214
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
Condliffe R; Kiely DG; Peacock AJ; Corris PA; Gibbs JS; Vrapi F; Das C; Elliot CA; Johnson M; DeSoyza J; Torpy C; Goldsmith K; Hodgkins D; Hughes RJ; Pepke-Zaba J; Coghlan JG
Am J Respir Crit Care Med; 2009 Jan; 179(2):151-7. PubMed ID: 18931333
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Sanges S; Sobanski V; Lamblin N; Hachulla E; Savale L; Montani D; Launay D
Rev Med Interne; 2024 Jan; 45(1):26-40. PubMed ID: 37925256
[TBL] [Abstract][Full Text] [Related]
11. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
[TBL] [Abstract][Full Text] [Related]
12. Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.
Cavagna L; Codullo V; Ghio S; Scirè CA; Guzzafame E; Scelsi L; Rossi S; Montecucco C; Caporali R
Medicine (Baltimore); 2016 Sep; 95(39):e4827. PubMed ID: 27684814
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension in connective tissue diseases.
Goldberg A
Cardiol Rev; 2010; 18(2):85-8. PubMed ID: 20160534
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
Ding Y; Qian J; Zhang S; Xu D; Leng X; Zhao J; Wang Q; Zhang W; Tian X; Li M; Zeng X
Int J Rheum Dis; 2022 Sep; 25(9):982-990. PubMed ID: 35699128
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances.
Kato M; Sugimoto A; Atsumi T
Expert Rev Clin Immunol; 2020 Oct; 16(10):993-1004. PubMed ID: 32975145
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in connective tissue diseases, new evidence and challenges.
Vonk MC; Vandecasteele E; van Dijk AP
Eur J Clin Invest; 2021 Apr; 51(4):e13453. PubMed ID: 33216992
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary arterial hypertension associated with connective tissue diseases].
Legendre P; Mouthon L
Presse Med; 2014 Sep; 43(9):957-69. PubMed ID: 25129118
[TBL] [Abstract][Full Text] [Related]
18. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
[TBL] [Abstract][Full Text] [Related]
19. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
Sundaram SM; Chung L
Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]